
Phuoc Tran
Examiner (ID: 2223, Phone: (571)272-7399 , Office: P/2668 )
| Most Active Art Unit | 2668 |
| Art Unit(s) | 2721, 2668, 2714, 2621, 2624, 2616, 2606 |
| Total Applications | 2031 |
| Issued Applications | 1724 |
| Pending Applications | 115 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20414120
[patent_doc_number] => 12497390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same
[patent_app_type] => utility
[patent_app_number] => 17/799054
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1896
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799054
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799054 | Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same | Feb 25, 2021 | Issued |
Array
(
[id] => 18146304
[patent_doc_number] => 20230020161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => Tricyclic Modulators of PP2A
[patent_app_type] => utility
[patent_app_number] => 17/907949
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907949 | Tricyclic Modulators of PP2A | Feb 25, 2021 | Abandoned |
Array
(
[id] => 20129111
[patent_doc_number] => 12371413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Method for preparing 2-iodoheterocyclic aryl ether at room temperature
[patent_app_type] => utility
[patent_app_number] => 18/012586
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012586
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012586 | Method for preparing 2-iodoheterocyclic aryl ether at room temperature | Feb 21, 2021 | Issued |
Array
(
[id] => 18739479
[patent_doc_number] => 20230348409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METAL CATALYST AND HYDROGEN GAS FREE APPROACHES FOR SELECTIVE REDUCTION OF ALDEHYDE TO METHYL GROUP OF DIFFERENT SUBSTITUTED FURANS
[patent_app_type] => utility
[patent_app_number] => 17/800701
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800701 | METAL CATALYST AND HYDROGEN GAS FREE APPROACHES FOR SELECTIVE REDUCTION OF ALDEHYDE TO METHYL GROUP OF DIFFERENT SUBSTITUTED FURANS | Feb 18, 2021 | Pending |
Array
(
[id] => 18360683
[patent_doc_number] => 20230142274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SUBSTITUTED ARYL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/800853
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800853 | SUBSTITUTED ARYL COMPOUND | Feb 18, 2021 | Abandoned |
Array
(
[id] => 17822639
[patent_doc_number] => 11427576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Indole compounds and their use
[patent_app_type] => utility
[patent_app_number] => 17/179286
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 67
[patent_no_of_words] => 55960
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179286 | Indole compounds and their use | Feb 17, 2021 | Issued |
Array
(
[id] => 16900608
[patent_doc_number] => 20210179524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ANTIMALARIAL COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/177314
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177314 | Antimalarial compositions and uses thereof | Feb 16, 2021 | Issued |
Array
(
[id] => 17082014
[patent_doc_number] => 20210277020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/174000
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174000 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | Feb 10, 2021 | Abandoned |
Array
(
[id] => 17036607
[patent_doc_number] => 20210253565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => MONOACYLGLYCEROL LIPASE MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/171559
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171559 | Monoacylglycerol lipase modulators | Feb 8, 2021 | Issued |
Array
(
[id] => 18328164
[patent_doc_number] => 11633377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Treatment of circadian rhythm disorders
[patent_app_type] => utility
[patent_app_number] => 17/169928
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 19217
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169928 | Treatment of circadian rhythm disorders | Feb 7, 2021 | Issued |
Array
(
[id] => 17314419
[patent_doc_number] => 20210403467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/167507
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17167507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/167507 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | Feb 3, 2021 | Abandoned |
Array
(
[id] => 18216391
[patent_doc_number] => 11591313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/168109
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 43935
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168109 | Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof | Feb 3, 2021 | Issued |
Array
(
[id] => 18202330
[patent_doc_number] => 11584712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Alkylamine-substituted perthiocarbamates as dual precursors to hydropersulfide and carbonyl sulfide
[patent_app_type] => utility
[patent_app_number] => 17/166434
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 28907
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166434 | Alkylamine-substituted perthiocarbamates as dual precursors to hydropersulfide and carbonyl sulfide | Feb 2, 2021 | Issued |
Array
(
[id] => 16854844
[patent_doc_number] => 20210155589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/164825
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164825 | Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide | Jan 31, 2021 | Issued |
Array
(
[id] => 18844430
[patent_doc_number] => 20230406834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/252300
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252300
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252300 | PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS | Jan 20, 2021 | Pending |
Array
(
[id] => 16839421
[patent_doc_number] => 20210147433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMINE AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 17/153727
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153727 | Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | Jan 19, 2021 | Issued |
Array
(
[id] => 19491597
[patent_doc_number] => 12110293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Substituted triazolo quinoxaline derivatives
[patent_app_type] => utility
[patent_app_number] => 17/152930
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53873
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 679
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152930 | Substituted triazolo quinoxaline derivatives | Jan 19, 2021 | Issued |
Array
(
[id] => 18802301
[patent_doc_number] => 11835457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Fluorescent composition for detecting biological material
[patent_app_type] => utility
[patent_app_number] => 17/151680
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4756
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151680 | Fluorescent composition for detecting biological material | Jan 18, 2021 | Issued |
Array
(
[id] => 17905454
[patent_doc_number] => 11459297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt
[patent_app_type] => utility
[patent_app_number] => 17/151901
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7722
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151901 | Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt | Jan 18, 2021 | Issued |
Array
(
[id] => 16961500
[patent_doc_number] => 20210212999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/151577
[patent_app_country] => US
[patent_app_date] => 2021-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151577 | Use of riluzole prodrugs to treat Alzheimer's disease | Jan 17, 2021 | Issued |